Analyze Diet
Journal of equine science2017; 28(4); 149-152; doi: 10.1294/jes.28.149

Equine ocular mast cell tumor: histopathological and immunohistochemical description.

Abstract: This report describes an ocular mast cell tumor in a 13-year-old female sport horse. Clinical examination revealed a solitary firm mass located in the ocular mucosa, protruding from behind the left lower eyelid. The lesion was surgically removed and submitted to histopathology. Microscopically, the mass was composed of sheets of well-differentiated neoplastic round cells circumscribed by delicate connective tissue. Positive Giemsa and Toluidine Blue staining confirmed the presence of cytoplasmic granules. Neoplastic cells showed strong membranous and mild diffuse cytoplasmic immunoreactivity for c-KIT and a low KI-67 proliferative index. Based on these findings, a diagnosis of ocular mast cell tumor was made. Six months after surgical removal, no evidence of ocular lesion recurrence was detected.
Publication Date: 2017-12-16 PubMed ID: 29270072PubMed Central: PMC5735312DOI: 10.1294/jes.28.149Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research paper reports a case of ocular mast cell tumor in a 13-year-old female sport horse, its associated clinical examination, histopathological and immunohistochemical findings and outcome of surgical removal of the tumor.

Introduction and Case Examination

  • This study features a case where a female sport horse developed an ocular mast cell tumor. The primary indication of this was a solitary firm mass noticeable on the ocular mucosa, specifically behind the left lower eyelid.
  • The mass was then surgically removed presumably because of the likely discomfort or potential harm it could bring to the horse. The removed tumor was subjected to further detailed evaluation and analysis to identify its histopathology and immunohistochemistry.

Test Results and Diagnosis

  • Conducting a microscopic examination of the mass revealed that the tumor was made up of sheets of well-differentiated neoplastic round cells. These cells were surrounded by intricate connective tissues.
  • The presence of cytoplasmic granules in the cells was validated through positive Giemsa and Toluidine Blue staining. This stained granules represent an essential characteristics of mast cells.
  • Moreover, neoplastic cells showed strong membranous immunoreactivity for c-KIT, which is a recognized marker for mast cells. Mild diffuse cytoplasmic immunoreactivity was also observed.
  • The cells showed a low KI-67 proliferative index, which suggests a lower growth speed of the tumor cells. This may explain why this was possibly not a malignant or aggressive tumor.
  • Based on these findings, a diagnosis of ocular mast cell tumor was confirmed.

Outcome after Surgical Removal

  • A follow-up examination done six months after the surgical removal of the tumor revealed no evidence of the recurrence of the lesion. This suggests that the surgical removal was successful and the horse remained free of such ocular lesion.

Cite This Article

APA
Flores AR, Azinhaga A, Pais E, Faria F, Nunes F, Gartner F, Amorim I. (2017). Equine ocular mast cell tumor: histopathological and immunohistochemical description. J Equine Sci, 28(4), 149-152. https://doi.org/10.1294/jes.28.149

Publication

ISSN: 1340-3516
NlmUniqueID: 9503751
Country: Japan
Language: English
Volume: 28
Issue: 4
Pages: 149-152

Researcher Affiliations

Flores, Ana R
  • Department of Pathology and Molecular Immunology of the Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, 4050-313 Porto, Portugal.
Azinhaga, Ana
  • Vetplus Veterinary Clinic Lda, 3200-532 Tomar, Portugal.
Pais, Elisabete
  • Vetplus Veterinary Clinic Lda, 3200-532 Tomar, Portugal.
Faria, Fátima
  • Department of Pathology and Molecular Immunology of the Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, 4050-313 Porto, Portugal.
Nunes, Francisco
  • Vasco da Gama University School (EUVG), 3020-210 Coimbra, Portugal.
Gartner, Fátima
  • Department of Pathology and Molecular Immunology of the Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, 4050-313 Porto, Portugal.
  • Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal.
  • Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), 4200-465 Porto, Portugal.
Amorim, Irina
  • Department of Pathology and Molecular Immunology of the Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, 4050-313 Porto, Portugal.
  • Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal.
  • Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), 4200-465 Porto, Portugal.

References

This article includes 22 references
  1. Altera K, Clark L. Equine cutaneous mastocytosis.. Pathol Vet 1970;7(1):43-55.
    pubmed: 4098483doi: 10.1177/030098587000700105google scholar: lookup
  2. Badial P.E., Rashmir-Raven A.M., Cagnini D.Q., Oliveira-Filho J.P., Cunha P.H.J., Kitchell B.E., Conceição L.G., Mochal C.A., Borges A.S.. Marjolin’s ulcer in two horses with hereditary equine regional dermal asthenia.. J. Equine Vet. Sci. 33: 515–522.
  3. Bosch G, Klein WR. Superficial keratectomy and cryosurgery as therapy for limbal neoplasms in 13 horses.. Vet Ophthalmol 2005 Jul-Aug;8(4):241-6.
  4. Cheville NF, Prasse K, van der Maaten M, Boothe AD. Generalized Equine Cutaneous Mastocytosis.. Vet Pathol 1972 Nov;9(6):394-407.
    pubmed: 29883994doi: 10.1177/030098587200900601google scholar: lookup
  5. Clarke L, Simon A, Ehrhart EJ, Mulick J, Charles B, Powers B, Duncan C. Histologic characteristics and KIT staining patterns of equine cutaneous mast cell tumors.. Vet Pathol 2014 May;51(3):560-2.
    pubmed: 23794148doi: 10.1177/0300985813493931google scholar: lookup
  6. Halse S, Pizzirani S, Parry NM, Burgess KE. Mast cell tumor invading the cornea in a horse.. Vet Ophthalmol 2014 May;17(3):221-7.
    pubmed: 23905672doi: 10.1111/vop.12084google scholar: lookup
  7. Hum S, Bowers JR. Ocular mastocytosis in a horse.. Aust Vet J 1989 Jan;66(1):32.
  8. Kitamura Y, Hirotab S. Kit as a human oncogenic tyrosine kinase.. Cell Mol Life Sci 2004 Dec;61(23):2924-31.
    pubmed: 15583854doi: 10.1007/s00018-004-4273-ygoogle scholar: lookup
  9. Kiupel M, Webster JD, Kaneene JB, Miller R, Yuzbasiyan-Gurkan V. The use of KIT and tryptase expression patterns as prognostic tools for canine cutaneous mast cell tumors.. Vet Pathol 2004 Jul;41(4):371-7.
    pubmed: 15232137doi: 10.1354/vp.41-4-371google scholar: lookup
  10. London CA, Galli SJ, Yuuki T, Hu ZQ, Helfand SC, Geissler EN. Spontaneous canine mast cell tumors express tandem duplications in the proto-oncogene c-kit.. Exp Hematol 1999 Apr;27(4):689-97.
    pubmed: 10210327doi: 10.1016/s0301-472x(98)00075-7google scholar: lookup
  11. Mair T.S., Krudewig C.. Mast cell tumour (mastocytosis) in the horse: a review of the literature and report of 11 cases.. Equine Vet. Educ. 20: 177–182.
  12. Malikides N., Reppas G., Hodgson J.L., Hodgson D.R.. Mast cell tumors in the horse: four case reports.. Equine Pract. 18: 12–17.
  13. Martin C.L., Leipold H.W.. Mastocytoma of the globe in a horse.. J. Am. Anim. Hosp. Assoc. 8: 32–34.
  14. McEntee MF. Equine cutaneous mastocytoma: morphology, biological behaviour and evolution of the lesion.. J Comp Pathol 1991 Feb;104(2):171-8.
    pubmed: 1865026doi: 10.1016/s0021-9975(08)80100-4google scholar: lookup
  15. Passantino L, Passantino G, Cianciotta A, Ribaud MR, Lo Presti G, Ranieri G, Perillo A. Expression of proto-oncogene C-kit and correlation with morphological evaluations in canine cutaneous mast cell tumors.. Immunopharmacol Immunotoxicol 2008;30(3):609-21.
    pubmed: 18608529doi: 10.1080/08923970801949265google scholar: lookup
  16. Patruno R, Marech I, Zizzo N, Ammendola M, Nardulli P, Gadaleta C, Introna M, Capriuolo G, Rubini RA, Ribatti D, Gadaleta CD, Ranieri G. c-Kit expression, angiogenesis, and grading in canine mast cell tumour: a unique model to study c-Kit driven human malignancies.. Biomed Res Int 2014;2014:730246.
    pmc: PMC4036613pubmed: 24900982doi: 10.1155/2014/730246google scholar: lookup
  17. Ressel L, Ward S, Kipar A. Equine Cutaneous Mast Cell Tumours Exhibit Variable Differentiation, Proliferation Activity and KIT Expression.. J Comp Pathol 2015 Nov;153(4):236-43.
    pubmed: 26292768doi: 10.1016/j.jcpa.2015.07.006google scholar: lookup
  18. Scott D.W., Miller W.H.. Equine Dermatology, 2nd ed.. .
  19. Scott D.W., Yager J.A., Wilcock B.P.. The skin and appendages.. pp. 531–738. In: Pathology of Domestic Animals, 4th ed. (Jubb, K.V.F., Kennedy, P.C., Palmer, N., eds.), Academic Press, San Diego..
  20. Shaiderman-Torban A., Tatz A., Oreff G., Brenner O., Dahan R., Ofri R., Kelmer G.. Mast cell tumour in the third eyelid of a mare.. Equine Vet. Educ. 1–5.
    doi: 10.1111/eve.12557google scholar: lookup
  21. Tan RH, Crisman MV, Clark SP, Gagea M, Zimmerman K. Multicentric mastocytoma in a horse.. J Vet Intern Med 2007 Mar-Apr;21(2):340-3.
  22. Ward DA, Lakritz J, Bauer RW. Scleral mastocytosis in a horse.. Equine Vet J 1993 Jan;25(1):79-80.

Citations

This article has been cited 0 times.